Abstract
In this work, water-compatible molecularly imprinted polymers (MIPs) were prepared for fast, accurate and selective solid-phase extraction of verapamil (VPM) from complex matrices such as biological fluids and human urine followed by its UV spectroscopic determination at 278 nm. The effective factors influencing the precipitation polymerization have been studied. Molecular recognition properties, binding capability and selectivity of the MIPs were evaluated and the results revealed that the obtained MIPs have high affinity for VPM in aqueous media. Equilibrium binding experiments were done to assess the performance of the MIP relative to non imprinted polymer (NIP). After optimization of molecularly imprinted solid-phase extraction (MISPE) method with 2 mL water plus 2 mL acetone as washing solvents and 5 mL of methanol and acetic acid (10:1, v/v) as elution solvent, successful imprinting was confirmed by comparison of the recoveries between NIP (4%) and MIP (97%) polymers. The binding capacity of the MIP for VPM was determined to be 196 mg g-1 (400 μmol g-1). Accuracy and precision were checked by the HPLC technique and the results did not present significant difference at 95% confidence levels according to the t-test.
Keywords: Molecularly imprinted polymer, Solid-phase extraction, Verapamil, Biological fluids, Human urine
Current Pharmaceutical Analysis
Title: Molecularly Imprinted Polymers for Selective Solid-Phase Extraction of Verapamil from Biological Fluids and Human Urine
Volume: 5 Issue: 3
Author(s): Mehran Javanbakht, Narges Shaabani, Majid Abdouss, Mohammad R. Ganjali, Ali Mohammadi and Parviz Norouzi
Affiliation:
Keywords: Molecularly imprinted polymer, Solid-phase extraction, Verapamil, Biological fluids, Human urine
Abstract: In this work, water-compatible molecularly imprinted polymers (MIPs) were prepared for fast, accurate and selective solid-phase extraction of verapamil (VPM) from complex matrices such as biological fluids and human urine followed by its UV spectroscopic determination at 278 nm. The effective factors influencing the precipitation polymerization have been studied. Molecular recognition properties, binding capability and selectivity of the MIPs were evaluated and the results revealed that the obtained MIPs have high affinity for VPM in aqueous media. Equilibrium binding experiments were done to assess the performance of the MIP relative to non imprinted polymer (NIP). After optimization of molecularly imprinted solid-phase extraction (MISPE) method with 2 mL water plus 2 mL acetone as washing solvents and 5 mL of methanol and acetic acid (10:1, v/v) as elution solvent, successful imprinting was confirmed by comparison of the recoveries between NIP (4%) and MIP (97%) polymers. The binding capacity of the MIP for VPM was determined to be 196 mg g-1 (400 μmol g-1). Accuracy and precision were checked by the HPLC technique and the results did not present significant difference at 95% confidence levels according to the t-test.
Export Options
About this article
Cite this article as:
Javanbakht Mehran, Shaabani Narges, Abdouss Majid, Ganjali R. Mohammad, Mohammadi Ali and Norouzi Parviz, Molecularly Imprinted Polymers for Selective Solid-Phase Extraction of Verapamil from Biological Fluids and Human Urine, Current Pharmaceutical Analysis 2009; 5(3) . https://dx.doi.org/10.2174/157341209788922011
DOI https://dx.doi.org/10.2174/157341209788922011 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Approaching Neurological Diseases to Reduce Mobility Limitations in Older Persons
Current Pharmaceutical Design Anti-Inflammatory and Anti-Apoptotic Effects of Levosimendan in Decompensated Heart Failure: A Novel Mechanism of Drug-Induced Improvement in Contractile Performance of the Failing Heart
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Targeting Kinin Receptors for the Treatment of Neurological Diseases
Current Pharmaceutical Design Postprandial Hypotension - Novel Insights into Pathophysiology and Therapeutic Implications
Current Vascular Pharmacology Antioxidant Properties of Crocus Sativus L. and Its Constituents and Relevance to Neurodegenerative Diseases; Focus on Alzheimer’s and Parkinson’s Disease
Current Neuropharmacology Possible Human Endogenous Cryogens
Current Protein & Peptide Science Under-Dosing of Etomidate for Rapid Sequence Intubation in the Emergency Department
Current Drug Safety Synthesis of 5-Arylidene Barbiturates: A Novel Class of DPPH Radical Scavengers
Letters in Drug Design & Discovery COVID-19 Effects on Geriatric Population and Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccines in the Prevention and Treatment of COVID-19
Current Medicinal Chemistry Why Methylene Blue Have to Be Always Present in the Stocking of Emergency Antidotes
Current Drug Targets Systemic Hypertension in Patients with Aortic Stenosis: Clinical Implications and Principles of Pharmacological Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Nutraceuticals and their Novel Drug Delivery System: A Boon to Human Health
Current Nutrition & Food Science Biologicals Dramatic Advances in the Treatment of Psoriasis
Current Pharmaceutical Design Current Research on Opioid Receptor Function
Current Drug Targets NO Chimeras as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Recent Achievements on Siderophore Production and Application
Recent Patents on Biotechnology Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor?
Current Cardiology Reviews The Detection of Adverse Events in Randomized Clinical Trials: Can we Really Say New Medicines are Safe?
Current Drug Safety Allergy to Miscellaneous Household Arthropods
Protein & Peptide Letters Recent Development in Applications of Important Biopolymer Chitosan in Biomedicine, Pharmaceuticals and Personal Care Products
Current Tissue Engineering (Discontinued)